Cargando…
Effect of apoptosis in neural stem cells treated with sevoflurane
BACKGROUND: At present, sevoflurane inhalation anesthesia used on infants is well-known. But long-time exposure to inhalation anesthetic could cause neurologic disorder, especially nerve degeneration in infant and developing brain. The central nervous system degeneration of infants could affect the...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359390/ https://www.ncbi.nlm.nih.gov/pubmed/25774088 http://dx.doi.org/10.1186/s12871-015-0018-8 |
_version_ | 1782361396360511488 |
---|---|
author | Qiu, Jianlei Shi, Pengcai Mao, Wude Zhao, Yuyi Liu, Wenshuai Wang, Yuelan |
author_facet | Qiu, Jianlei Shi, Pengcai Mao, Wude Zhao, Yuyi Liu, Wenshuai Wang, Yuelan |
author_sort | Qiu, Jianlei |
collection | PubMed |
description | BACKGROUND: At present, sevoflurane inhalation anesthesia used on infants is well-known. But long-time exposure to inhalation anesthetic could cause neurologic disorder, especially nerve degeneration in infant and developing brain. The central nervous system degeneration of infants could affect the memory and cognitive function. γ-Aminobutyric acid (GABA) is a known inhibitory neurotransmitter in central nervous system. Inhalation anesthetic sevoflurane may activate GABA(A) receptor to inhibit central nervous system, leading to apoptosis of neural degeneration, cognitive dysfunction in the critical period of brain development. METHODS: Neural stem cells were derived from Wistar embryos, cultured in vitro. Third generation of neural stem cells were randomly divided into four groups according to cultured suspension: Sevoflurane group (Group S), GABA(A) receptor antagonists, Bicuculline group (Group B), Sevoflurane + GABA(A) receptor antagonists, Bicuculline group (Group S + B), dimethyl sulphoxide (DMSO) group (Group D). Group B and Group D did not receive sevoflurane preconditioning. Group S and Group S + B were pretreated with 1 minimum alveolar concentration (MAC) sevoflurane for 0 h, 3 h, 6 h, and 12 h. Group S + B and Group B were pretreated with bicuculline (10 uM). Group D was treated with DMSO (10 uL/mL). After treatments above, all groups were cultured for 48 h. Then we measured the cells viability by Cell Counting Kit (CCK-8) assay, cytotoxicity by Lactate Dehydrogenase (LDH) assay, apoptosis ratio with Annexin V/propidium iodide (PI) staining by flow cytometry, and the expression of GABA(A)R, anti-apoptotic protein Bcl-2, pro-apoptotic protein Bax and Caspase-3 by western blotting. RESULTS: After exposing to sevoflurane for 0 h, 3 h, 6 h, and 12 h with 1MAC, we found that cell viability obviously decreased and cytotoxicity increased in time-dependent way. And Annexin V/PI staining indicated increased apoptosis ratio by flow cytometry. The protein level of GABA(A) receptor, pro-apoptotic protein Bax and apoptosis protein Caspase-3 increased; while anti-apoptotic protein Bcl-2 decreased. And bicuculline could reverse all detrimental results caused by sevoflurane. CONCLUSION: Sevoflurane can inhibit the central nervous system by activating GABA(A), resulting in apoptosis of neural stem cells, thus leading to the NSCs degeneration. |
format | Online Article Text |
id | pubmed-4359390 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43593902015-03-15 Effect of apoptosis in neural stem cells treated with sevoflurane Qiu, Jianlei Shi, Pengcai Mao, Wude Zhao, Yuyi Liu, Wenshuai Wang, Yuelan BMC Anesthesiol Research Article BACKGROUND: At present, sevoflurane inhalation anesthesia used on infants is well-known. But long-time exposure to inhalation anesthetic could cause neurologic disorder, especially nerve degeneration in infant and developing brain. The central nervous system degeneration of infants could affect the memory and cognitive function. γ-Aminobutyric acid (GABA) is a known inhibitory neurotransmitter in central nervous system. Inhalation anesthetic sevoflurane may activate GABA(A) receptor to inhibit central nervous system, leading to apoptosis of neural degeneration, cognitive dysfunction in the critical period of brain development. METHODS: Neural stem cells were derived from Wistar embryos, cultured in vitro. Third generation of neural stem cells were randomly divided into four groups according to cultured suspension: Sevoflurane group (Group S), GABA(A) receptor antagonists, Bicuculline group (Group B), Sevoflurane + GABA(A) receptor antagonists, Bicuculline group (Group S + B), dimethyl sulphoxide (DMSO) group (Group D). Group B and Group D did not receive sevoflurane preconditioning. Group S and Group S + B were pretreated with 1 minimum alveolar concentration (MAC) sevoflurane for 0 h, 3 h, 6 h, and 12 h. Group S + B and Group B were pretreated with bicuculline (10 uM). Group D was treated with DMSO (10 uL/mL). After treatments above, all groups were cultured for 48 h. Then we measured the cells viability by Cell Counting Kit (CCK-8) assay, cytotoxicity by Lactate Dehydrogenase (LDH) assay, apoptosis ratio with Annexin V/propidium iodide (PI) staining by flow cytometry, and the expression of GABA(A)R, anti-apoptotic protein Bcl-2, pro-apoptotic protein Bax and Caspase-3 by western blotting. RESULTS: After exposing to sevoflurane for 0 h, 3 h, 6 h, and 12 h with 1MAC, we found that cell viability obviously decreased and cytotoxicity increased in time-dependent way. And Annexin V/PI staining indicated increased apoptosis ratio by flow cytometry. The protein level of GABA(A) receptor, pro-apoptotic protein Bax and apoptosis protein Caspase-3 increased; while anti-apoptotic protein Bcl-2 decreased. And bicuculline could reverse all detrimental results caused by sevoflurane. CONCLUSION: Sevoflurane can inhibit the central nervous system by activating GABA(A), resulting in apoptosis of neural stem cells, thus leading to the NSCs degeneration. BioMed Central 2015-03-07 /pmc/articles/PMC4359390/ /pubmed/25774088 http://dx.doi.org/10.1186/s12871-015-0018-8 Text en © Qiu et al.; licensee BioMed Central. 2015 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Qiu, Jianlei Shi, Pengcai Mao, Wude Zhao, Yuyi Liu, Wenshuai Wang, Yuelan Effect of apoptosis in neural stem cells treated with sevoflurane |
title | Effect of apoptosis in neural stem cells treated with sevoflurane |
title_full | Effect of apoptosis in neural stem cells treated with sevoflurane |
title_fullStr | Effect of apoptosis in neural stem cells treated with sevoflurane |
title_full_unstemmed | Effect of apoptosis in neural stem cells treated with sevoflurane |
title_short | Effect of apoptosis in neural stem cells treated with sevoflurane |
title_sort | effect of apoptosis in neural stem cells treated with sevoflurane |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359390/ https://www.ncbi.nlm.nih.gov/pubmed/25774088 http://dx.doi.org/10.1186/s12871-015-0018-8 |
work_keys_str_mv | AT qiujianlei effectofapoptosisinneuralstemcellstreatedwithsevoflurane AT shipengcai effectofapoptosisinneuralstemcellstreatedwithsevoflurane AT maowude effectofapoptosisinneuralstemcellstreatedwithsevoflurane AT zhaoyuyi effectofapoptosisinneuralstemcellstreatedwithsevoflurane AT liuwenshuai effectofapoptosisinneuralstemcellstreatedwithsevoflurane AT wangyuelan effectofapoptosisinneuralstemcellstreatedwithsevoflurane |